CRESCENT BIOPHARMA INC.

Historical 13F Holders

Symbol
CBIO
CUSIP
G2545C104
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for G2545C104 since 12/18/2024, largest first.

Filer % of Class Filed
Fairmount Funds Management LLC 13D/A
16.5% 7/20/2026
Event 7/16/2026
FMR LLC 13G/A
15.0% 2/5/2026
Event 12/31/2025
Biotechnology Value Fund L P 13G/A
9.8% 11/16/2026
Event 9/30/2026
Vestal Point Capital, LP 13G/A
8.1% 11/16/2026
Event 9/30/2026
ForGrowth III PA B.V. 13G
6.1% 12/11/2025
Event 12/8/2025
Venrock Healthcare Capital Partners III, L.P. 13G/A
5.9% 11/16/2026
Event 9/30/2026
BlackRock, Inc. 13G 5.6% 10/27/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Tang Capital Management LLC 13G/A
4.2% 5/15/2026
Event 3/31/2026
Logos Global Management LP 13G/A
4.1% 8/14/2025
Event 6/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 105 40.4 M $590M
2026 Q2 80 29.1 M $524M
2026 Q1 60 25.1 M $461M
2025 Q4 56 23.7 M $281M
2025 Q3 41 11.3 M $135M
2025 Q2 31 10.8 M $174M